Glutathione transferase Kappa (GSTK1-1) also termed disulfide bond-forming oxidoreductase A-like protein (DsbA-L) has been implicated in the post-translational multimerization of adiponectin and has been negatively correlated with obesity in mice and humans. We investigated adiponectin in Gstk1 À/À mice and surprisingly found no difference in the levels of total serum adiponectin or the level of high molecular weight (HMW) multimers when compared with normal controls. Non-reducing SDS-polyacrylamide gel electrophoresis and western blotting also showed a similar distribution of low, middle and HMW multimers in normal and Gstk1 À/À mice. Variation in adiponectin has been correlated with glucose tolerance and with the levels of phosphorylated AMP-kinase but we found similar glucose tolerance and similar levels of phospho 5-AMP-activated protein kinase in normal and Gstk1 À/À mice. Consequently, our findings suggest that GSTK1-1 is not absolutely required for adiponectin multimerization in vivo and alternate pathways may be activated in GSTK1-1 deficiency.
INTRODUCTION
Adiponectin is an adipokine primarily secreted by white adipose tissue that has a variety of roles in the regulation of glucose and fatty acid metabolism via its induction of fatty acid oxidation, suppression of hepatic gluconeogenesis and enhancement of liver and muscle insulin sensitivity. 1 Low levels of circulating adiponectin are associated with obesity and insulin resistance, 2, 3 and high levels correlate with protection against obesityrelated pathologies including type 2 diabetes and metabolic syndrome, 4 hypertension, 5 atherosclerosis 6 and non-alcoholic fatty liver disease. 7 Adiponectin circulates in the blood as three major disulfide-linked oligomeric forms; a low molecular weight trimer, a middle molecular weight hexamer and high molecular weight (HMW) 12 --18 multimers. There is substantial evidence that the different oligomers have different biological functions. 1, 8 A recent study in 3T3-L1 cells, 9 reported that adiponectin oligomerization was promoted by glutathione transferase kappa (GSTK1-1) and that knockdown of GSTK1-1 severely diminished the levels of secreted HMW adiponectin in 3T3-L1 adipocytes. GSTK1-1 is expressed in a variety of tissues including white adipose tissue, the principal source of adiponectin in vivo.
9 --11 The expression of GSTK1-1 was also negatively correlated with obesity in mice and humans, and it was therefore proposed as a new target for the development of drugs for the treatment of insulin resistance and associated metabolic disorders. 9 Although GSTK1-1 has glutathione transferase activities like the cytosolic GSTs, it is localized in mitochondria and peroxisomes 12 and its structure differs significantly from those of the cytosolic and microsomal GSTs. The Kappa class GSTs exhibit a similar fold to that of the bacterial disulfide bond-forming proteins such as disulfide bond-forming oxidoreductase A (DsbA). 11, 13, 14 The structural similarity of GSTK1-1 to DsbA has lead to the suggestion that it should be renamed DsbA-Like (DsbA-L); 9 however, it is also similar to the bacterial 2 --hydroxychromene-2 --carboxylate isomerases. 13 Although we have shown that GSTK1-1 has significant glutathione transferase activity in vitro, 13 we developed GstK1 knockout mice to investigate its biological role in vivo. We noted that GSTK1-1 deficiency causes glomerular nephropathy involving basement membrane changes, podocyte foot process effacement and microalbuminuria. 15 Interestingly, this phenotype is similar to that occurring in adiponectin-deficient mice, which exhibit albuminuria and fusion of podocyte foot processes. 16 Given the apparent role of GSTK1-1 in oligomerization of adiponectin and the similarities in the phenotypes of GSTK1-1 and adiponectin-deficient mice, we have now investigated the impact of GSTK1-1 deficiency on adiponectin multimerisation and adiponectin-mediated functions in GstK1 À/À mice.
MATERIALS AND METHODS Mice
The generation of the GstK1 À/À mice used in this study has been described. 15 Male GstK1 À/À mice and their wild-type littermate controls aged between 12 and 20 weeks were used throughout this study. The high-fat diet (Specialty Feeds, Glen Forrest, WA, Australia) was administered ad libitum for 8 weeks and consisted of 23% fat, 0.19% cholesterol with 43% of the total digestible energy derived from lipids.
Glucose tolerance tests
Mice were fasted for 6 h before blood glucose determination using an Optium Xceed glucometer (Abbot Diagnostics, VIC, Australia). Mice were then injected intraperitoneally with 2g/kg D-glucose (Sigma Aldrich, Castle Hill, NSW, Australia) and blood glucose was measured every 15 min for 1 h.
Total and HMW-specific adiponectin enzyme-linked immunosorbent assays (ELISAs)
Total (R and D systems, Minneapolis, MN, USA) and HMW-specific (Alpco Diagnostics, Salem, NH, USA) serum adiponectin levels were measured using commercial ELISA kits as directed by the supplier.
Western blotting
For serum adiponectin, 2.5 ml of a 1 in 1500 dilution of mouse serum was resolved per lane on a non-reducing, denaturing 4 --20% SDS-polyacrylamide gel (Biorad, Hercules, CA, USA). For total-and phospho-5-AMPactivated protein kinase (AMPK), livers were homogenized in T-PER buffer (Thermo Scientific, Rockford, IL, USA) supplemented with protease (Roche, Castle Hill, NSW, Australia) and phosphatase inhibitors (Merck, Darmstadt, Germany). Proteins were quantified with a BCA protein assay kit (Thermo Scientific) and 20 mg of protein resolved per lane. Gels were blotted on to Immobilon PVDF membranes (Millipore, Billerica, MA, USA) and blocked overnight at 4 1C in 2% BSA in Tris-buffered saline (100 mM Tris, 150 mM NaCl, 0.1% Tween 20, pH 7.5) The membranes were probed with anti-adiponectin (Millipore), anti total-or anti-phospho Thr172-AMPK antibodies (Cell Signalling Technology, Danvers, MA, USA). Membranes were probed with HRP-conjugated secondary antibodies (Dako, Produktionsvej, Denmark), developed using enhanced chemiluminescence reagents (GE Healthcare Bio-Sciences, Rydalmere, NSW, Australia) and exposed to X-ray film.
RESULTS
Initially, we used western blotting to confirm that GSTK1-1 was expressed in white adipose tissue of normal mice and is absent in Gstk1 À/À mice (Figure 1a ). Our initial measurements of total serum adiponectin failed to reveal any difference between GstK1 À/À mice and wild-type þ / þ and GSTK1 À/À mice fed either a normal chow (e) or a high-fat diet (f ). N ¼ 6 for all groups. (g) Hepatic levels of phospho-and total-AMPK levels detected by western blotting. For all blots, a representative pair of one of four age-and sex-matched pairs of GSTK1 þ / þ / GSTK1 À/À mice is shown.
controls (Figure 1b) . This indicates that GSTK1-1 does not influence the overall synthesis and turnover of adiponectin in vivo. Since GSTK1-1 has been implicated in the posttranslational oligomerization of adiponectin, we determined the level of HMW adiponectin in mice that were fed either a chow or a high-fat diet by a HMW-specific adiponectin immunoassay. 17 There was no difference in the serum HMW adiponectin level of wild-type and GstK1 À/À mice that were maintained on a normal chow diet (Figure 1c) . Although wild-type mice consuming a highfat diet exhibited a slightly lower mean level of HMW adiponectin compared with GstK1 À/À mice, the difference was not statistically significant (Figure 1c) . Both wild-type and GstK1 À/À mice on highfat diet exhibited higher levels of HMW adiponectin when compared with normal chow-fed mice. This likely reflects the increase in adiposity of the mice, which leads to initial increases in adiponectin levels before their decline upon the development of chronic obesity, as has been observed. 18 In addition, the weight of GstK1 À/À mice was not different compared with controls on either diet (data not shown).
In order to examine the size distribution of serum adiponectin, we used non-reducing SDS-polyacrylamide gel electrophoresis to fractionate serum from mice fed a high-fat for 8 weeks and characterized the adiponectin multimers by western blotting. We found a similar distribution of low molecular weight, middle molecular weight and HMW multimers in both wild type and GstK1 À/À mice ( Figure 1d ). As adiponectin levels have been correlated with improved glucose tolerance, we subjected wild-type and GstK1 À/À mice fed either a normal chow (Figure 1e ) or a high-fat diet (Figure 1f ) to an intraperitoneal glucose tolerance test. No differences in either fasting blood glucose concentrations or in the clearance of glucose from the blood were found between wild-type and GstK1 À/À mice on either diet. Adiponectin exerts beneficial effects on insulin sensitivity via phosphorylation and activation of AMPK. 19 In our study, however, no difference in the levels of hepatic phospho-AMPK between wild-type and GstK1 À/À mice fed a high-fat diet were detected (Figure 1g ).
DISCUSSION
Adiponectin is of great interest because of its critical role in maintaining insulin sensitivity and its anti-inflammatory actions. 20 The post-translational multimerization of adiponectin into low molecular weight, middle molecular weight and HMW species is of particular interest because the beneficial metabolic effects of adiponectin have been largely attributed to the HMW form. 1, 8 As GSTK1-1 has been implicated in the post-translational oligomerization of adiponectin and its expression in adipose tissue has been negatively correlated with the metabolic syndrome in mice and humans, 9 we expected that GSTK1-1-deficient mice might suffer from a major deficiency in adiponectin oligomers and have a phenotype that reflected abnormalities in insulin sensitivity. In a previous study, 15 we found that GstK1 À/À mice had slightly lower serum adiponectin levels (P ¼ 0.047), but this difference was not present in the current study with a larger number of mice. The present studies have surprisingly not revealed a change in total or HMW serum adiponectin or in the pattern of multimerization. Moreover, we did not find any evidence of lowered glucose tolerance or phospho-AMPK levels, phenotypes that would be predicted if Gstk1 À/À mice exhibited a marked deficiency of HMW adiponectin.
Several proteins including endoplasmic reticulum-associated protein 44 (ERp44) and endoplasmic oxidoreductin-1 --like protein (Ero1-La) have been implicated in adiponectin multimerization, trafficking and secretion (for review see Wang et al. 1 ). It is possible that these or additional molecular chaperone proteins might also promote the disulfide-linked multimerization of adiponectin and provide alternative compensatory pathways for oligomerization in the absence of GSTK1-1.
The similarities in the renal pathology (albuminuria and podocyte foot process abnormalities) observed in GSTK1- [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and adiponectin-deficient 16 mice are curious, given the lack of effect GSTK1-1 deficiency appears to have on adiponectin multimerization. However, as some functions of adiponectin appear to be oligomer-specific and as the size distribution of oligomers within the middle molecular weight and HMW categories is broad, (see Figure 1d) it is possible that GSTK1-1 is responsible for the formation of a particular subset of oligomers that are not distinguished by the methods we have used in this study.
These data suggest that any attempt to pharmacologically upregulate molecular chaperones that contribute to adiponectin multimerisation may not result in a net increase of HMW adiponectin. Therefore, the lack of effect of GSTK1-1 deficiency on adiponectin multimerisation noted in this study has a negative impact on the proposal that GSTK1-1 is a target for therapeutic intervention in insulin resistance and related disorders.
